Le Lézard
Classified in: Covid-19 virus
Subjects: CALENDAR OF EVENTS, ANNUAL MEETINGS

High Arctic Annual General and Special Meeting Conference Call


NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW

CALGARY, Alberta, May 12, 2020 (GLOBE NEWSWIRE) -- High Arctic Energy Services Inc. (TSX: HWO) (the "Corporation" or "High Arctic"). 

AGM CONFERENCE CALL DETAILS ? Thursday May 14, 2020 at 3pm MST

All shareholders, business analysts and other interested parties are encouraged to listen to the Corporation's Annual General and Special Meeting ("AGM") by way of teleconference on Thursday May 14, 2020 at 3pm MST at the following numbers:

Please dial into the conference call 10 minutes before the start of the call.  The meeting may not begin until a few minutes after 3pm.  The High Arctic's First Quarter results are anticipated to be issued after markets close on Thursday May 14, 2020, and should shareholders or analysts wish to contact the Corporation, contact details are noted at the bottom of this News Release. 

The Corporation continues to monitor the development of the current coronavirus outbreak ("COVID-19"). In light of the rapidly evolving public health guidelines related to COVID-19 and in order to comply with the measures imposed by the federal and provincial governments, the Corporation strongly encourages shareholders to VOTE BY PROXY rather than attend the meeting in person through one of the following channels:

All votes must be received by 3:00 p.m. (MST) on Tuesday May 12, 2020.  Late proxies may be accepted or rejected by the Chairman of the AGM at his discretion, and the Chairman is under no obligation to accept or reject late proxies.

While registered Shareholders and proxyholders are entitled to attend the Meeting in person, we reserve the right to limit the number of people at the AGM to such number of attendees as is permitted under Alberta law, as a result of COVID-19.

If you hold your Common Shares in a brokerage account, you are a non-registered Shareholder or beneficial Shareholder. Beneficial Shareholders who hold their Common Shares through a bank, broker or other financial intermediary should carefully follow the instructions found on the form of proxy or voting instruction form provided to them by their intermediary, in order to cast their vote.

Your participation as a Shareholder is very important to the Corporation.  Please ensure your Common Shares are represented at the AGM. 

About High Arctic

High Arctic is a publicly traded company listed on the Toronto Stock Exchange under the symbol "HWO".  The Corporation's principal focus is to provide drilling and specialized well completion services, equipment rentals, snubbing and other services to the oil and gas industry.

For further information contact:

Michael J. MaguireChristopher Ames
Chief Executive OfficerVice-President Finance & Interim CFO
P: (587) 318-3826P: (587) 318-2218
E: [email protected]E: [email protected]



These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: